DS
DNA SEQ 2, INC.
SEC filingPharmaceuticals · Vista, CA
Amount raised$1.2Msold at filing
Total offering$1.2M
Investors in the raise32count reported to the SEC
FiledMar 11, 2026first sale Apr 10, 2024
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Thomas M. WheelerDirector
Benjamin M. AndersonDirector
Stuart E. SiegelDirector
Janusz Maria SowadskiDirector
Eric Maria LadizinskyDirector
Andrew NappinExecutive Officer
Executive officers, directors and promoters as listed on the Form D.